title: Hb Canterbury [beta112(G14)Cys-->Phe]: a new, mildly unstable variant.
authors.affiliation: Molecular Pathology Laboratory, Canterbury Health Laboratories, Christchurch, New Zealand. steve.brennan@chmeds.ac.nz
authors.forename: Stephen O
authors.initials: SO
authors.lastname: Brennan
authors.forename: Howard C
authors.initials: HC
authors.lastname: Potter
authors.forename: Lia M
authors.initials: LM
authors.lastname: Kubala
authors.forename: Susan A
authors.initials: SA
authors.lastname: Carnoutsos
authors.forename: Martin M
authors.initials: MM
authors.lastname: Ferguson
mesh_terms: D019840:2-Propanol / Q000494:pharmacology; D019943:Amino Acid Substitution; D011232:Chemical Precipitation; D005914:Globins / Q000737:chemistry / Q000235:genetics*; D006223:Hamartoma Syndrome, Multiple / Q000097:blood / Q000150:complications; D006455:Hemoglobins, Abnormal / Q000737:chemistry / Q000235:genetics / Q000302:isolation & purification*; D006801:Humans; D008297:Male; D008875:Middle Aged; D020125:Mutation, Missense; D010449:Peptide Mapping; D017354:Point Mutation; D011489:Protein Denaturation; D021241:Spectrometry, Mass, Electrospray Ionization
chemical_list: D006455:Hemoglobins, Abnormal; C465355:hemoglobin Canterbury; D005914:Globins; D019840:2-Propanol